Cochlear Limited, which creates implantable hearing devices, has taken a technological leap forward with a device that syncs up with various Apple products. The Nucleus 7 Sound Processor, which was ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

In a report released on February 14, David Low from J.P. Morgan upgraded Cochlear Limited (CHEOF – Research Report) to a Buy, with a price target of A$311.00. The company’s shares closed last Friday ...

LONE TREE, Colo., June 2, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today the commercial release of the new Cochlear™ Baha® 7 ...

Using visual support technology powered by TechSee, Cochlear has been able to bolster their customer experience by focusing on the needs of recipients through the use of Augmented Reality. NEW YORK, ...

Citi analyst Mathieu Chevrier maintained a Sell rating on Cochlear Limited (CHEOF – Research Report) today and set a price target of A$255.00. The company’s shares closed last Wednesday at $235.10.

Cochlear Limited (CHEOF) announced an update on their ongoing clinical study. Study Overview: Cochlear Limited has recently completed an early feasibility study titled An Early Feasibility, ...

LONE TREE, Colo., Feb. 25, 2026 /PRNewswire/ -- In celebration of International Cochlear Implant Day, Cochlear North America is proud to announce the recipients of the 2026 Cochlear Academic ...

Cochlear Limited ((AU:COH)) has held its Q4 earnings call. Read on for the main highlights of the call. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, ...